192 related articles for article (PubMed ID: 12574954)
1. Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA.
Kärppä M; Syrjälä P; Tolonen U; Majamaa K
J Neurol; 2003 Feb; 250(2):216-21. PubMed ID: 12574954
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA.
Kärppä M; Herva R; Moslemi AR; Oldfors A; Kakko S; Majamaa K
Brain; 2005 Aug; 128(Pt 8):1861-9. PubMed ID: 15857931
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.
Uusimaa J; Moilanen JS; Vainionpää L; Tapanainen P; Lindholm P; Nuutinen M; Löppönen T; Mäki-Torkko E; Rantala H; Majamaa K
Ann Neurol; 2007 Sep; 62(3):278-87. PubMed ID: 17823937
[TBL] [Abstract][Full Text] [Related]
4. Muscle computed tomography patterns in patients with the mitochondrial DNA mutation 3243A>G.
Kärppä M; Mahjneh I; Karttunen A; Tolonen U; Majamaa K
J Neurol; 2004 May; 251(5):556-63. PubMed ID: 15164188
[TBL] [Abstract][Full Text] [Related]
5. Pigmentary retinopathy in patients with the MELAS mutation 3243A-->G in mitochondrial DNA.
Latvala T; Mustonen E; Uusitalo R; Majamaa K
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):795-801. PubMed ID: 12397426
[TBL] [Abstract][Full Text] [Related]
6. Small-fiber neuropathy and the 3243A>G mutation in mitochondrial DNA.
Henning F; Oey PL; Oerlemans WG; Wokke JH
J Neurol; 2007 Sep; 254(9):1281-2. PubMed ID: 17410323
[No Abstract] [Full Text] [Related]
7. Nerve conduction abnormalities in patients with MELAS and the A3243G mutation.
Kaufmann P; Pascual JM; Anziska Y; Gooch CL; Engelstad K; Jhung S; DiMauro S; De Vivo DC
Arch Neurol; 2006 May; 63(5):746-8. PubMed ID: 16682545
[TBL] [Abstract][Full Text] [Related]
8. ["MELAS" (A3243G) mutation of mitochondrial DNA: a study of the relationships between the clinical phenotype in 19 patients and morphological and molecular data].
Laforêt P; Ziegler F; Sternberg D; Rouche A; Frachon P; Fardeau M; Eymard B; Lombès A
Rev Neurol (Paris); 2000 Dec; 156(12):1136-47. PubMed ID: 11139730
[TBL] [Abstract][Full Text] [Related]
9. Muscle 3243A-->G mutation load and capacity of the mitochondrial energy-generating system.
Janssen AJ; Schuelke M; Smeitink JA; Trijbels FJ; Sengers RC; Lucke B; Wintjes LT; Morava E; van Engelen BG; Smits BW; Hol FA; Siers MH; Ter Laak H; van der Knaap MS; Van Spronsen FJ; Rodenburg RJ; van den Heuvel LP
Ann Neurol; 2008 Apr; 63(4):473-81. PubMed ID: 18306232
[TBL] [Abstract][Full Text] [Related]
10. Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders.
Mimaki M; Hatakeyama H; Ichiyama T; Isumi H; Furukawa S; Akasaka M; Kamei A; Komaki H; Nishino I; Nonaka I; Goto Y
Mitochondrion; 2009 Apr; 9(2):115-22. PubMed ID: 19460299
[TBL] [Abstract][Full Text] [Related]
11. Association of the MELAS m.3243A>G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection.
Marotta R; Reardon K; McKelvie PA; Chiotis M; Chin J; Cook M; Collins SJ
J Clin Neurosci; 2009 Sep; 16(9):1223-5. PubMed ID: 19502062
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features.
Logullo F; Censori B; Danni M; Del Pesce M; Di Bella P; Provinciali L
Electromyogr Clin Neurophysiol; 1992; 32(10-11):515-20. PubMed ID: 1332841
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology.
Goldfarb AR; Latov N; Brannagan TH; Chin RL; de Sousa EA; Sander HW
Neurol Neurophysiol Neurosci; 2006 Dec; ():7. PubMed ID: 17260084
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and progression of mitochondrial diseases: a study of 50 patients.
Arpa J; Cruz-Martínez A; Campos Y; Gutiérrez-Molina M; García-Rio F; Pérez-Conde C; Martín MA; Rubio JC; Del Hoyo P; Arpa-Fernández A; Arenas J
Muscle Nerve; 2003 Dec; 28(6):690-5. PubMed ID: 14639582
[TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
Kaufmann P; Engelstad K; Wei Y; Jhung S; Sano MC; Shungu DC; Millar WS; Hong X; Gooch CL; Mao X; Pascual JM; Hirano M; Stacpoole PW; DiMauro S; De Vivo DC
Neurology; 2006 Feb; 66(3):324-30. PubMed ID: 16476929
[TBL] [Abstract][Full Text] [Related]
16. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype.
Kanaumi T; Hirose S; Goto Y; Naitou E; Mitsudome A
Pediatr Neurol; 2006 Mar; 34(3):235-8. PubMed ID: 16504796
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
Munakata K; Iwamoto K; Bundo M; Kato T
Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy of mitochondrial myopathies.
Mizusawa H; Ohkoshi N; Watanabe M; Kanazawa I
Rev Neurol (Paris); 1991; 147(6-7):501-7. PubMed ID: 1660182
[TBL] [Abstract][Full Text] [Related]
19. Second lumbrical-interossei latency difference: A strong predictor of median neuropathy at the wrist in uremic patients.
Sharma VK; Wilder-Smith EP
Neurol Neurophysiol Neurosci; 2007 Jul; ():2. PubMed ID: 17700926
[TBL] [Abstract][Full Text] [Related]
20. Population prevalence of the MELAS A3243G mutation.
Manwaring N; Jones MM; Wang JJ; Rochtchina E; Howard C; Mitchell P; Sue CM
Mitochondrion; 2007 May; 7(3):230-3. PubMed ID: 17300999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
